Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced business updates and financial results for the...
Source: marketscreener.com